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Summary  Cardiac  catheterization  has  contributed  to  the  progress  made  in  the  management
of patients  with  congenital  heart  disease  (CHD).  First,  it  allowed  clariﬁcation  of  the  diagnostic
assessment  of  CHD,  by  offering  a  better  understanding  of  normal  cardiac  physiology  and  the
pathophysiology  and  anatomy  of  complex  malformations.  Then,  it  became  an  alternative  to
surgery and  a  major  component  of  the  therapeutic  approach  for  some  CHD  lesions.  Nowadays,
techniques have  evolved  and  cardiac  catheterization  is  widely  used  to  percutaneously  close
intracardiac  shunts,  to  relieve  obstructive  valvar  or  vessel  lesions,  and  for  transcatheter  valve
replacement.  Accurate  imaging  is  mandatory  to  guide  these  procedures.  Cardiac  imaging  during
catheterization  of  CHD  must  provide  accurate  images  of  lesions,  surrounding  cardiac  structures,
medical devices  and  tools  used  to  deliver  them.  Cardiac  imaging  has  to  be  ‘real-time’  with  an
excellent temporal  resolution  to  ensure  ‘eyes—hands’  synchronization  and  ‘device—target  area’
accurate positioning.  In  this  comprehensive  review,  we  provide  an  overview  of  conventional
cardiac imaging  tools  used  in  the  catheterization  laboratory  in  daily  practice,  as  well  as  the
effect of  recent  evolution  and  future  imaging  modalities.
© 2016  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  Le  cathétérisme  cardiaque  a  contribué  aux  progrès  réalisés  dans  la  prise  en  charge
des cardiopathies  congénitales.  Il  a  tout  d’abord  permis  de  mieux  appréhender  l’anatomie
et la  physiologie  des  malformations  complexes.  Le  cathétérisme  est  de  nos  jours  de  plus  en
plus interventionnel,  suppléant  ou  complétant  la  chirurgie  cardiaque.  Il  permet  entre  autres
l’occlusion de  shunt,  la  dilatation  de  valves,  vaisseaux  ou  conduits  sténosés  et  le  remplacement
valvulaire  percutané.  Une  imagerie  de  précision  est  nécessaire  en  salle  de  cathétérisme  pour
guider ces  interventions.  Cette  imagerie  doit  permettre  de  bien  visualiser  les  lésions  à  traiter,
les structures  avoisinantes,  les  dispositifs  médicaux  et  les  systèmes  permettant  de  les  achem-
iner. Cette  imagerie  doit  être  temps-réel  pour  permettre  à  l’opérateur  une  bonne  coordination
« main—œil  » et  « prothèse—zone  cible  ».  Dans  cette  revue  générale,  nous  abordons  les  avan-
tages et  les  inconvénients  des  outils  d’imagerie  actuellement  utilisés  en  salle  de  cathétérisme,
l’impact des  évolutions  récentes  ainsi  que  les  perspectives  futures.
© 2016  Elsevier  Masson  SAS.  Tous  droits  réservés.
r
r
w
s
H
c
T
b
i
p
c
t
w
o
C
the  ‘key  in  the  lock’  to  summarize  its  effect  on  the  diagnosisIntroduction
Cardiac  catheterization  has  contributed  to  the  progress
made  in  the  management  of  patients  with  congenital  heart
disease  (CHD).  It  is  widely  used  to  percutaneously  close
intracardiac  shunts  [1,2],  to  relieve  obstructive  valvar  or
vessel  lesions,  and  for  transcatheter  valve  replacement
[3—5].  Cardiac  imaging  has  always  been  closely  related  to
the  development  of  cardiac  catheterization.  Catheteriza-
tion  became  feasible  under  ﬂuoroscopy  [6].  It  remains  the
cornerstone  of  cardiac  imaging,  but  two-dimensional  (2D)
and  three-dimensional  (3D)  echocardiography  has  become  a
complementary  useful  tool  in  the  catheterization  laboratory
[7].  Fusion  imaging  between  ﬂuoroscopy  and  echocardiog-
raphy  or  tomography  further  assist  complex  percutaneous
procedures  [8,9].  Multi-modalities  imaging  in  the  catheter-
ization  laboratory  is  thus  nowadays  available.  In  this  com-
prehensive  review,  we  provide  an  overview  of  conventional
cardiac  imaging  tools  used  in  catheterization  laboratories
in  daily  practice,  as  well  as  the  effect  of  the  recent  evo-
lution  of  and  future  imaging  modalities.  First,  conventional
ﬂuoroscopy  and  its  improvement  are  described.  Then,  the
effect  of  multimodal  echocardiography  is  discussed  with
a
i
megards  to  CHD  current  practice  in  the  catheterization  labo-
atory.  Other  3D  imaging  techniques  are  further  described,
ith  their  potential  application  in  CHD.  The  focus  is  on  the
trengths  and  weaknesses  of  each  imaging  modality.
ow the feasibility of cardiac
atheterization was demonstrated
he  ﬁrst  cardiac  catheterization  in  man  was  demonstrated
y  X-ray  imaging  in  1929  [6]. At  age  25,  while  receiving  clin-
cal  instruction  in  surgery,  Werner  Forssmann  (1904—1979)
assed  a  urethral  catheter  through  one  of  his  left  ante-
ubital  veins  until  its  tip  entered  the  right  atrium.  He
hen  walked  to  the  radiology  department  where  an  X-ray
as  taken  [6].  Together  with  Cournand  and  Richards,  he
btained  the  Nobel  Prize  in  1956.  During  his  Nobel  lecture,
ournand  stated  elegantly  that  cardiac  catheterization  wasnd  treatment  of  heart  diseases.  In  the  1950s,  dynamic
mages  of  heart  cavities  were  feasible  through  the  develop-
ent  of  cineangiograms  on  roll  ﬁlms  and  image  intensiﬁers.
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E30  
ercutaneous  treatments,  such  as  pulmonary  valvar  stenosis
ilation  (1953)  and  balloon  atrial  septostomy  (1966)  then
ecame  feasible  under  ﬂuoroscopy  guidance  [10,11].
luoroscopy: the cornerstone of
nterventional catheterization
emporal  resolution  and  image  cadence  with  ﬂuoroscopy  are
ery  high.  The  frame  rate  in  routine  practice  is  adjusted
etween  10  and  30  images  per  second  to  limit  irradia-
ion.  Fluoroscopy  allows  a  user-friendly  real-time  cardiac
maging.  The  radio-opacity  of  medical  devices,  wires  and
elivery  sheaths  is  high,  facilitating  interventional  proce-
ures.  Excellent  temporal  resolution  ensures  ‘eyes—hands’
ynchronization  and  ‘device—target  area’  accurate  position-
ng.  Since  the  very  beginning  of  cardiac  catheterization,  and
till  today,  almost  all  diagnostic  and  interventional  catheter-
zation  procedures  are  performed  under  ﬂuoroscopy.  Thus,
ccording  to  most  operators,  ﬂuoroscopy  is  the  cornerstone
f  catheterization  and  no  other  cardiac  imaging  technique
s  absolutely  necessary  (Table  1).
mprovement in ﬂuoroscopy imaging
igital subtraction angiography
igital  subtraction  angiography  is  a  ﬂuoroscopy  technique
sed  to  enhance  blood  vessel  visualization.  Contrast  injec-
ion  is  delayed  by  around  2  seconds  after  the  beginning  of
mage  acquisition.  The  frame  rate  is  adjusted  to  4—6  images
er  second.  Final  images  are  produced  by  subtracting  the
re-contrast  image  (‘the  mask’)  from  later  images.  Digi-
al  subtraction  angiography  is  useful  in  CHD  catheterization
12],  for  example  to  delineate  aorto-pulmonary  collaterals
n  Tetralogy  of  Fallot  with  pulmonary  atresia,  arterio-venous
stula  and  coronary  ﬁstula  (Fig.  1,  Video  1).
ono versus biplane tube
ome  CHD  catheterization  laboratories  rely  on  a  single  X-
ay  tube,  whereas  the  value  of  biplane  tube  is  advocated  in
ther  centres  and  recommendations  [13].  Biplane  orthogo-
al  imaging  is  recommended  to  ensure  the  accuracy  of  target
esion  description.  Nevertheless,  all  diagnostic  and  interven-
ional  catheterization  procedures  are  feasible  using  a  single
obile  tube.  Dual  tube  imaging  allows  faster  biplane  imag-
ng  during  the  same  contrast  injection.  Thus,  in  some  long
rocedures,  such  as  pulmonary  valve  replacement,  it  may
ecrease  the  amount  of  injected  contrast  and  help  prevent
ontrast-induced  nephropathy.  Today,  however,  with  the
vailability  of  low-osmolar  iodine  contrast,  this  is  no  longer  a
ritical  issue  in  paediatric  cardiology,  but  it  may  be  more  rel-
vant  in  adult  CHD.  Dual  tube  imaging  is  particularly  useful
n  procedures  involving  the  great  vessels.  It  allows  biplane
maging  without  moving  the  tubes  or  the  examination  table.
eference  images  are  available  for  the  interventionist,  with
natomical  markers  such  as  bones  without  position  changes,
acilitating  device  or  balloon  positioning.  Dual  tube  imaging
ay  theoretically  increase  ﬂuoroscopy  time,  but  attention
s  taken  by  the  operator  to  use  simultaneous  dual  tube
maging  in  selected  cases.  Furthermore,  in  single  X-ray
ube  imaging,  the  ﬂuoroscopy  time  may  be  increased  by
d
e
f
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ube  position  movement  and  image  adjustment  when  mul-
iple  working  incidences  are  necessary.  Furthermore,  with
mprovements  in  tube  technology,  the  results  of  a  recent
tudy  demonstrated  that  biplane  imaging  with  ﬂat-panel
etectors  produced  less  irradiation  than  a  conventional  sys-
em  equipped  with  an  image  intensiﬁer  [14].
Spatial  relationship  may  also  be  investigated  through
otational  angiography  [15].  A  dynamic  angiogram  is
ecorded  during  a  semi-rotation  of  the  X-ray  tube  (Video  2).
owever,  it  remains  a  2D-imaging  technique  with  the  same
imitations.  Furthermore,  it  does  not  provide  easily  compre-
ensive  video  sequences  and  irradiation  is  increased.  Thus,
t  remains  little  used  in  clinical  practice.
imits of ﬂuoroscopy
trength  and  weaknesses  of  ﬂuoroscopy  are  displayed  in
able  2.
rradiation: the Achilles heel
hort-term  deterministic  effects  of  ionizing  radiation  are
irectly  proportional  to  the  dose  received  and  result  from
rradiation  at  high  doses.  These  complications  are  very  rare,
ince  effective  doses  usually  range  from  only  2  to  12  mSv
or  the  most  frequent  procedures  [16].  However,  concerns
ave  been  raised  regarding  stochastic  effects  of  low  doses
hat  can  appear  later,  randomly,  such  as  cancer  in  patients,
ut  also  in  operators  [17].  Children  are  more  susceptible
han  adults  to  the  effects  of  ionizing  radiation.  Thus  the  pri-
ary  radiation  safety  principle  is  to  avoid  irradiation  when
 non-ionizing  imaging  technique  is  alternatively  available.
evertheless,  evolving  technology  with  new-generation  X-
ay  tubes,  ﬂat-panel  detectors  and  decreasing  irradiation
lgorithms  have  signiﬁcantly  decreased  X-ray  tube  irradia-
ion  with  comparable  image  quality  [14].
maging limits
luoroscopy  by  itself  does  not  allow  visualization  of  smooth
ardiac  and  vessel  tissues  —  only  calciﬁed  lesions  are  seen.
ogether  with  iodine  contrast  injection,  a  good  visualiza-
ion  of  cardiac  cavities  and  vessels  is  provided.  Proximal
ulmonary  artery  and  aortic  lesions  are  well  described.  How-
ver,  intracardiac  shunts  such  as  atrial  septal  defect  (ASD)
nd  ventricular  septal  defect  (VSD)  remain  poorly  visualized.
Furthermore,  ﬂuoroscopy  provides  only  2D  images.  Close
tructures  such  as  distal  pulmonary  vessels  may  be  super-
mposed;  and  valvar  annulus  and  vessel  diameters  may  not
e  accurately  measured.  If  the  projection  is  not  perfectly
ligned  with  the  target  vessels,  foreshortening  may  lead
o  an  underestimation  of  the  length  of  the  lesion.  Multi-
le  images  are  therefore  needed  to  obtain  a  comprehensive
patial  assessment.
D and 3D echocardiography
chocardiography  provides  real-time  images  without  irra-
iation,  and  temporal  resolution  is  excellent.  Nowadays,
chocardiography  is  a  multi-modality  tool.  Moving  quickly
rom  one  option  to  another,  the  echographer  can  dis-
lay  real-time  2D  images  facilitating  device  positioning,
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Table  1 Use  of  cardiac  imaging  modalities  during  catheterization  of  CHD.
Fluoroscopy  Echocardiography  CT  scan
Roadmap-
ping
3D
printing
Conventional  DSA  TTE  TOE  ICE  2D  3D  Echonavigator®
ASD  closure +++
Feasible
without  in
some  teams
[26]
—  ++
Sufﬁcient  in
some  teams
[33]
++  +  ++
Sufﬁcient  in
most  teams
[33]
++
Complementary
useful  tool  but
not  essential
[2]
++
Interest
remains  to  be
demonstrated
—  ?
VSD closure +++  —  ++  ++  —  ++
Sufﬁcient  in
most  teams
+
May  be  a
complementary
useful  tool  but
not  essential
+
Interest
remains  to  be
demonstrated
—  ?
PDA closure +++
Without  in
premature
[28]
—  +
Only  used  in
echo-guided
closure  in
premature
—  —  +  —  —  —  —
Pulmonary
valvuloplasty
+++ —  —  —  —  —  —  —  —  —
Aortic valvuloplasty +++  —  +
Useful  but  not
essential
+  —  ++  +  —  —  ?
Foetal aortic
valvuloplasty
—  —  +++  —  —  ++  —  —  —  —
Mitral valvuloplasty +++  —  ++  —  —  ++  +  —  —  —
Aortic (re)coarctation
stenting
+++  —  —  —  —  —  —  —  +  ?
Pulmonary artery
angioplasty
+++  +  —  —  —  —  —  —  +  ?
Pulmonary valve
replacement
+++  —  —  —  +
Used  by
some  teams
in  complex
cases  but
not
essential
[21]
+
Used  by
some  teams
in  complex
cases  but
not
essential
[21]
—  ?  +  +
Tricuspid valve
replacement
+++  —  +  +  +  +  ?  +  —  ?
+++: imaging technique used currently and essential for procedural success, interest well demonstrated; ++: imaging technique used currently but not essential, interest demonstrated; +:
imaging technique used by some teams but interest less well demonstrated; ?: imaging technique utility remains to be demonstrated; —: imaging technique not useful; 2D: two-dimensional;
3D: three-dimensional; ASD: atrial septal defect; CHD: congenital heart disease; CT: computed tomography; DSA: digital subtraction angiography; ICE: intracardiac echocardiography;
PDA: persistent ductus arteriosus; TOE: transoesophageal echocardiography; TTE: transthoracic echocardiography; VSD: ventricular septal defect.
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Table  2  Strength  and  weaknesses  of  imaging  modality  during  catheterization  of  CHD.
Fluoroscopy  Echocardiography  Echonavigator® 3D-CT
roadmapping
Conventional  DSA  TTE  TOE  ICE  2D  3D
Minimum  number  of
operators
1  1  1  2  2  2  1
Ease  of  use  +++  ++  +++  ++  +  +++  +  +  +
Imaging  cadency  +++  +  +++  +++  +++  +++  +  ++  —
Real-time  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  No
3D  No  No  Yes  Yesa Yes  No  Yes  Yes  Yes
Irradiation  +++  ++  —  —  —  —  —  +/—b +/—b
Medical  device
visualization
+++  +  ++  ++  ++  ++  ++  +++  +++
Wires  visualization  +++  +  +  +  +  +  —  +++  +++
Target  lesion
visualization
Requires
iodine
contrast
+++
For  intrac-
ardiac
shunt,
valves  and
ventricular
outﬂow
tracts
+++
For  intrac-
ardiac
shunt  and
valves
+++
For  ventricular
outﬂow  tracts
and  vessels
Side  effects  Irradiation  Irradiation  None  Oesophageal
perforation
Vascular
access
None  None  None  None
+++: very good/high; ++: quite good/high; +: less good/high; —: bad/low; 2D: two-dimensional; 3D: three-dimensional; CHD: congenital heart disease; CT: computed tomography; DSA:
digital subtraction angiography; ICE: intracardiac echocardiography; TOE: transoesophageal echocardiography; TTE: transthoracic echocardiography.
a In children > 18—20 kg.
b Depending on procedure type.
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Figure 1. Digital subtraction angiography. Digital subtraction angiographies were performed in a neonate with Tetralogy of Fallot and
pulmonary atresia with multiple aorto-pulmonary collaterals. A. Small right upper lobe collateral. B. Pulmonary artery bifurcation irrigated
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the right middle lobe. D. Non-communicating collateral for the left
show  3D  volume-rendering  images  to  better  delineate  the
anatomical  features  of  intracardiac  lesions  and  explore  the
3D  dataset  multiplanar  reconstruction  to  provide  accurate
measures  (Fig.  2).  There  is  now  much  literature  displaying
the  superiority  of  3D  over  2D  echocardiography  alone,  in  the
catheterization  laboratory  [2,18].
Strength  and  weaknesses  of  various  echocardiographic
modalities  are  displayed  in  Table  2.
Transthoracic versus transoesophageal
echocardiography
Transthoracic  echocardiography  (TTE)  is  the  pivotal  cardiac
imaging  tool  for  CHD  management.  A  complete  anatomical
assessment  is  always  performed  by  TTE  before  and  after
cardiac  catheterization.  In  the  catheterization  laboratory,
TTE  is  sometimes  used  during  intracardiac  shunting  closure
procedures  such  as  ASD  and  VSD.  TTE  and  ﬂuoroscopy  are
not  used  concomitantly,  given  that  the  echo  probe  and  the
echographer’s  hand  will  appear  on  the  X-ray  ﬁeld.  Transoe-
sophageal  echocardiography  (TOE)  may  help  to  overcome
this  issue.  The  intra-oesophageal  probe  is  thin  and  does
not  disturb  the  ﬂuoroscopy  guidance.  It  allows  a  real-time
guidance  of  intracardiac  shunt  closure  nicely  displaying  the
device,  the  ASD  or  the  VSD,  and  the  surrounding  structures.
New  miniaturized  intra-oesophageal  probes  allow  its  use
in  small  children  and  even  in  neonates  [19]. However,  3D
p
t
o
‘lobe and the left inferior lobe. C. Non-communicant collateral for
rior lobe.
echnology  is  currently  only  available  in  adult  probes,  which
ave  been  used  safely  in  children  weighing  at  least  18—20  kg
2]. The  main  issue  of  TOE  is  that  it  requires  deep  seda-
ion  and  often  orotracheal  intubation  for  patient  comfort.
ome  argue  that  cardiac  catheterization  in  paediatric  cardi-
logy  is  always  performed  under  sedation.  However,  in  our
xperience,  a  smooth  sedation  without  orotracheal  intu-
ation  is  sufﬁcient  in  most  cases.  In  children,  ASD  closure
an  safely  be  performed  under  local  anaesthesia  and  TTE
uidance  (unpublished  data),  whereas  in  our  experience,
or  patient  comfort,  TOE  requires  sedation  and  orotracheal
ntubation.  Moreover,  in  some  procedures,  such  as  complex
SD  closure,  visualization  of  the  inferior  rim  is  sometimes
ifﬁcult,  and  complementary  TTE  may  be  required.  A  sec-
nd  rare  but  major  issue  is  the  risk  of  intra-oesophageal
esions.  Intra-oesophageal  perforation  has  occasionally  been
escribed  in  adults  as  well  as  children.  Thirdly,  the  close
elationship  between  the  echographer  and  the  X-ray  tube
esults  in  echographer  irradiation  and  particular  attention
hould  be  paid  by  the  operator  to  limit  ﬂuoroscopy.
Finally,  whereas  catheterization  and  TTE  can  be  per-
ormed  alternately  by  the  same  operator,  real-time  guidance
y  TOE  requires  a  second  echographer.  The  efﬁcacy  of  the
rocedure  relies  on  the  experience  of  both  operators  and  a
rustworthy  relationship,  but  ultimately  the  responsibility
f  the  procedure  is  endorsed  by  the  interventionist.  This
judge  and  adviser  situation’  has  been  widely  explored  in
134  S. Hascoët  et  al.
Figure 2. 3D echocardiography of an atrial septal defect (ASD) in multiplanar reformatting mode. A 3D volume dataset was acquired
in zoom-3D mode. Multiplanar reformatting mode allows visualization of the ASD and its rims through three axes and a volume-rendering
en-face view. Two axes are manually and orthogonally positioned on the ASD rims (all white arrows) such that the third axis provides an
en-face view of the defect. The circumference and maximal and minimal diameters can be accurately measured. AV: aortic valve; IVC:
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sycho-sociology  literature.  The  interventional  cardiologist
eeds  to  communicate  effectively  with  the  echocardio-
rapher  in  the  catheterization  laboratory  to  obtain  the
ppropriate  projections  that  will  guide  his  manipulations.
n  the  other  hand,  the  echocardiographer  has  to  be
amiliar  with  all  steps  of  the  procedure  and  the  particular
references  and  needs  of  the  interventionist.  Furthermore,
he  echocardiographer  has  to  be  patient  since  some  pro-
edures,  such  as  para-valvular  leakages  or  VSD  closure,
an  be  long.  Thus,  echocardiography  in  the  catheterization
aboratory  appears  to  be  a  particular  subspecialty  of  CHD
chocardiography  and  speciﬁc  training  should  be  promoted.
ntracardiac echocardiography
ntracardiac  echocardiography  is  now  available  with  colour
oppler,  2D  and  3D  technology.  It  requires  a  second  venous
emoral  approach  (8  or  10  Fr).  It  has  been  safely  and  accu-
ately  used  to  accomplish  ASD  closure  and  percutaneous
ulmonary  valve  implantation  [20,21].  A  learning  curve  is
ecessary  to  understand  how  to  manipulate,  by  rotation,
he  intracardiac  probe  positioned  in  the  right  atrium.  Then,
ntracardiac  echocardiography  can  be  used  by  the  inter-
entionist  alone,  close  to  the  femoral  access.  The  major
imitation  is  the  high  cost  of  the  single-use  probe.
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chocardiography and ﬂuoroscopy fusion
maging
ne  of  the  main  issues  in  cardiac  imaging  for  percutaneous
reatment  of  CHD  is  the  inability  to  simultaneously  visu-
lize  the  anatomy,  the  catheter  and  the  devices  using  a
ingle  imaging  modality.  When  multiple  imaging  modalities
re  used  in  the  catheterization  laboratory,  they  are  usually
resented  to  the  operator  in  separate  screens  and  the  oper-
tor  has  to  fuse  the  displayed  pictures  mentally.  A  recent
mprovement  by  cardiac  imaging  industrialists  has  been  to
dd  the  strength  of  each  imaging  modality  into  so-called
usion  imaging.  To  be  accurate,  this  integrated  approach
equires  a real-time  co-registration  of  both  imaging  modal-
ties.  Furthermore,  the  real-time  merged  image  orientation
ust  be  appropriate  to  guide  the  intervention.
chonavigator®
chonavigator® (Philips  Healthcare,  Best,  the  Netherlands)
s  a  software  tool  that  enables  real-time  image  synchroniza-
ion  and  fusion  of  2D  and  3D-TOE  with  ﬂuoroscopy  images.
he  system  places  the  two  imaging  modalities  in  the  same
oordinate  system  and  is  based  on  the  localization  and  track-
ng  of  the  TOE  probe.  After  synchronization  of  TOE  and
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Figure 3. Echonavigator® during atrial septal defect closure. On a large ﬂat screen, four views are displayed simultaneously to the
operators in real-time. A. Standard echocardiography TOE view (as on the echocardiographer’s screen). B. Free 3D image that can be
 as t
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trotated or cropped. C. Echography image in the same orientation
device.
ﬂuoroscopy  images,  the  system  automatically  tracks  and
follows  the  movements  of  the  C-arm  gantry.  When  the  C-
arm  is  moved,  echocardiography  images  are  updated  and
reconstructed  with  the  same  orientation.  On  a  large  ﬂat
screen,  four  views  are  displayed  simultaneously  to  the  oper-
ators  in  real-time  (Fig.  3).  The  ﬁrst  release  of  the  software
also  allowed  the  placement  of  markers,  in  real-time,  on
speciﬁc  points  of  interest  on  the  echocardiography  images
that  were  automatically  displayed  on  the  ﬂuoroscopy  images
(Fig.  4).  In  the  second  release  of  the  software,  real-time  3D
echocardiography  images  can  be  merged  and  displayed  with
the  ﬂuoroscopy  image  (Fig.  3).  The  safety  and  feasibility
[
e
i
Figure 4. Echonavigator®. A. Points of interest (green, pink and white
on the 3D volume and can be displayed on 3D echocardiography (B) and he C-arm gantry. D. X-ray view with merged 3D live echo of the
f  this  novel  technology  have  been  demonstrated  in  adult
tructural  heart  diseases  (MitraClip  interventions  and  left
trial  appendage  closure)  [8,22].  This  software  tool  seems
nteresting  to  facilitate  complex  percutaneous  procedure
nd  decrease  procedure  length  as  well  as  radiation  dose.
owever,  there  is  currently  no  data  to  support  these  aspi-
ations.  In  a  ﬁrst  comparative  study  using  the  MitraClip
rocedure,  with  or  without  Echonavigator®, the  total  radia-
ion  dose  and  procedure  time  were  not  signiﬁcantly  different
8]. However,  this  study  was  biased  by  a  learning  curve
ffect  and  a  selection  bias  given  more  complex  procedures
n  the  Echonavigator® group.  Nevertheless,  Echonavigator®
) were positioned on the 2D-TEE view. These points are then locked
simultaneously on the X-ray view (C).
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oftware  requires  a  3D-TOE  probe  that  can  only  be  used
n  patients  weighing  20—25  kg.  Thus,  this  technology  is  not
urrently  available  in  small  children.
cho-guided catheterization without
uoroscopy
cho-guided  Rashkind  procedures  performed  in  the  delivery
oom  or  in  the  neonatal  intensive  care  unit  provide  evi-
ence  that  some  catheterizations  can  be  performed  safely
ithout  the  need  for  ﬂuoroscopy  [23].  In  these  cases,  the
eason  was  the  emergency  indication  rather  than  the  radio-
rotection  principle.  However,  given  the  risks  related  to
rradiation  in  children  [24,25],  some  teams  have  developed
eart  catheterization  without  ﬂuoroscopy.
Percutaneous  ASD  closure  can  be  performed  under
chocardiographic  guidance  alone  without  irradiation  in
arefully  selected  cases  [26].  However,  echocardiography  is
f  limited  value  to  follow  wires  and  catheters  within  the
eart  or  to  assess  the  position  of  the  wire  distally  in  the
eft  superior  pulmonary  vein.  Thus,  most  operators  still  rely
n  ﬂuoroscopy  to  check  wire  and  device  positions.  In  expe-
ienced  hands,  this  procedure  is  fast,  requiring  only  a  few
inutes  of  ﬂuoroscopy  [27];  the  danger  of  this  irradiation
ose  remains  to  be  demonstrated.
Persistent  ductus  arteriosus  closure  is  performed  in  rou-
ine  practice  under  ﬂuoroscopy  guidance  only  [1].  In  preterm
eonates,  percutaneous  closure  using  new  devices  has  been
eveloped  in  some  centres  as  an  alternative  to  surgical  liga-
ion  [28].  Echocardiographic  guidance  alone  seems  efﬁcient
nd  the  better  imaging  option  in  experienced  hands.  Con-
rast  injection  should  be  avoided  given  the  renal  fragility
nd  the  hydro-electrolytical  disorders  in  this  particular  indi-
ation  [28].
xamples of procedures with
chocardiography  guidance: intracardiac
hunt  closure
se  of  echocardiography  in  CHD  interventional  catheteriza-
ion  is  displayed  in  Table  1.
trial septal defect
ercutaneous  closure  of  ostium  secundum  ASD  is  the  treat-
ent  of  choice  in  most  cases  [29].  The  procedure  is
erformed  under  ﬂuoroscopy  and  echocardiography  guid-
nce.  Echocardiography  is  useful  during  the  procedure  to
ssess  the  morphology,  number  and  sizes  of  the  ASD.  How-
ver,  it  is  essential  to  check  the  good  positioning  of  the
evice  and  the  relationship  with  surrounding  structures
efore  device  release.  TOE  was  used  in  the  pivotal  trial
f  the  Amplatzer  septal  occluder,  and  continues  to  be  the
ost  common  ultrasound  technology  used  for  deﬁnitive  ASD
ssessment,  device  selection  and  device  guidance  during
mplantation  [30,31].
While  2D-TOE  was  successfully  used  in  earlier  studies,  3D-
OE  appears  to  be  more  accurate  for  the  assessment  of  ASD
ize  and  morphology  [2]  (Fig.  5).
The  Zoom-3D-real-time  mode  is  particularly  interesting
o  display  an  en-face  view  of  the  ASD  from  the  right  or
eft  side,  making  the  ASD  shape  visually  available  for  the
p
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nterventionist.  X-plane  mode  allows  a  2D  view  and  mea-
urement  of  the  ASD  diameter  according  to  two  orthogonal
lanes.  A single-beat  full-volume  pyramidal  dataset  of
0  ×  30◦ with  imaging  cadency  up  to  25  Hz  allows  a  mul-
iplanar  reformatting  navigation  to  measure  the  maximal
nd  minimal  diameters  and  the  area  of  the  ASD.  However,
perators  must  be  aware  of  potential  artefacts  such  as
titching  artefacts,  dropout  artefacts,  blurring  artefacts,
looming  artefacts  and  rail-road  shaped  artefacts  [32].
Nevertheless,  practices  still  vary  widely  according  to
perator,  experience  and  centre.  In  various  studies,  ASD
losure  has  been  safely  performed  under  2D-  and  3D-TOE,
D-TTE  and  2D-ICE  [2,20,33]. According  to  the  Marie-
annelongue  Hospital  experience,  when  balloon  sizing  is
sed,  2D-TTE  appears  as  efﬁcient  as  2D-TOE  in  children
unpublished  data).  On  the  other  hand,  according  to  Necker
ospital  experience,  2D-TOE  may  be  sufﬁcient  to  per-
orm  ASD  closure  without  the  need  for  balloon  calibration,
ecreasing  ﬂuoroscopy  time  to  a  minimum  of  30  seconds
27]. In  Toulouse  children’s  hospital,  3D-TOE  is  used  in  cur-
ent  practice  and  the  effect  of  Echonavigator® in  ASD  closure
Figs.  3  and  4)  is  under  investigation.
entricular septal defects
ercutaneous  closure  of  VSD  remains  controversial.  When
his  procedure  is  performed  in  carefully  selected  cases,
ercutaneous  closure  of  muscular  or  membranous  VSD  is
uided  by  ﬂuoroscopy  and  echocardiography.  Echocardiog-
aphy,  particularly  in  3D  mode,  is  essential  to  assess  VSD
orphology  and  size  and  thus  device  choice  (Fig.  6).
In  most  cases,  an  arterio-venous  loop  is  performed  and
he  device  is  partially  deployed  in  the  aorta  and  then  gen-
ly  pulled  back  across  the  aortic  valve  in  the  left  ventricle
nd  positioned  across  the  VSD.  TOE  is  useful  during  this  pro-
edure  to  follow  the  course  of  the  device  and  its  relation
o  the  aortic  valve.  The  device  position  and  its  relationship
ith  surrounding  structures  are  assessed  before  release  by
OE  or  TTE.
ffect of echocardiography guidance in aortic
alvuloplasty
ercutaneous  balloon  valvuloplasty  is  the  ﬁrst-line  treat-
ent  in  many  centres  for  the  management  of  valvar  aortic
tenosis  in  neonates  and  children  [34—36].  The  procedure
s  performed  under  ﬂuoroscopy  and  is  successful  in  about
5%  of  cases  [35]. The  main  issue  is  the  risk  of  aortic  regur-
itation;  therefore,  some  centres  still  consider  surgery  as
he  method  of  choice.  The  risk  of  aortic  regurgitation  is
ncreased  in  the  case  of  previous  aortic  regurgitation  and
s  related  to  the  balloon/aortic  annulus  diameter  ratio  [37].
ortic  regurgitation  may  occur  with  an  oversized  balloon,
hereas  residual  stenosis  may  occur  with  an  undersized  bal-
oon.  The  accurate  measurement  of  the  aortic  annulus  is
ssential.  Aortic  annulus  can  be  measured  on  angiographic
mages,  but  several  studies  have  demonstrated  that  accu-
ate  annulus  geometry  and  measurements,  as  well  as  better
rocedure  results,  are  obtained  using  echocardiographic
uidance,  particularly  with  the  3D  mode  [18,38,39].  Even
n  critical  neonatal  aortic  stenosis,  TOE  guidance  is  feasible
sing  a  micro-TOE  probe  [19].
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Figure 5. Transcatheter valve replacement with 3D-CT Roadmapping. The angulation of the X-ray system is optimized using the fused
image. Coronary arteries can be localized on the fused image (black arrow: right coronary artery; white arrow: left coronary artery) before
(A) and after (B) aortography. C and D. The Melody valve was then implanted (white arrows) with good scaffolding of the aneurism developed
on the distal suture of the homograft (black arrows).
Figure 6. Double atrial septal defect (ASD) closure under 3D echocardiography. A. En-face view of the atrial septum. Two distant ASDs
of approximately the same size are observed as well as the rims. View of the ﬁrst closure device from the (B) left and (C) right sides. A
guidewire was introduced into the second defect (D: right view; E: left 
atrial septal defect.view). F. Left en-face view of the two devices after closure. ASD:
138  S. Hascoët  et  al.
Figure 7. Ventricular septal defect (VSD) closure under 2D-3D echocardiography. A. Apical four-chamber 2D view of a medio-muscular
VSD. B. 3D en-face view of the defect from the right ventricle (RV). The VSD is above the septal band. C. A guidewire is positioned through
the defect with an arterio-venous loop. D and E. A device is positioned through the defect. A residual shunt is observed behind the device
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ther 3D imaging modalities
D computed tomography Roadmapping
D  image  data  sets  obtained  from  rotational  angiography,
ardiac  magnetic  resonance  imaging  (MRI)  and  computed
omography  (CT)  scans  can  be  integrated  with  ﬂuoroscopy.
irst,  a  pre-procedural  3D  image  volume  data  set  is
cquired.  Then,  a  3D  reconstruction  and  segmentation
f  the  structure  of  interest  is  performed.  Finally,  a  3D
econstructed  model  is  integrated  to  ﬂuoroscopy  during
he  catheterization  procedure.  Thus,  image  fusion  could
mprove  the  2D  spatial  visualization  of  images  from  a
edical  examination  by  merging  the  3D  model  with  con-
entional  interventional  X-ray  images.  CT  is  the  method
f  choice  for  pre-procedural  3D  image  acquisition  given  its
igh  image  resolution  of  both  the  vasculature  and  the  air-
ay,  facilitating  segmentation.  This  imaging  technique  has
een  previously  developed  in  interventional  neuro-radiology
40—43],  abdominal  and  vascular  interventional  radiology
44—47]  and  cardiology  for  electro-anatomical  mapping  dur-
ng  atrial  ﬁbrillation  ablation  procedures  [48—51].
3D-Roadmapping  has  emerged  as  a  promising  modal-
ty  applicable  for  the  catheterization  of  complex  CHD
9,52—54].  Various  points  of  interest  of  this  integration
ethod  have  been  suggested.  First,  due  to  the  full  3D  reg-
stration  between  the  CT  volume  and  the  X-ray  system,  the
otation  of  the  CT  volume  is  linked  to  the  rotation  of  the
-ray  system,  allowing  one  to  assess  the  best  position  for
he  X-ray  system  to  face  the  anomaly  without  the  need  to
o  any  X-ray.  Thus,  irradiation  may  be  decreased  by  this
u
g
peft ventricle (LV). AV: aortic valve; MV: mitral valve; PV: pulmonary
echnique  [9]. Second,  during  the  procedure,  image  fusion
llows  for  good  positioning  of  catheters,  guides  and  balloons
r  devices,  without  injection  of  contrast.  Third,  because
t  is  possible  to  add  speciﬁc  thoracic  structures  to  the  3D
odel,  it  improves  the  visualization  of  anatomical  structures
hat  surround  the  target  lesion.  Thus,  it  could  reduce  the
eed  for  angiographies  looking  for  their  localization  before
nterventional  catheterization.  For  example,  aortography  to
ocalize  the  coronary  tree  before  transcatheter  pulmonary
alve  replacement  is  not  mandatory  because  coronary  arter-
es  can  be  localized  on  image  fusion  (Fig.  7).
One  major  limitation  of  3D  rotational  angiography,  CT  or
RI  for  ﬂuoroscopic  roadmaps  is  that  these  images  are  not
cquired  in  real-time.  Changes  in  patient  position  and  dis-
ortion  of  the  target  lesion  by  the  catheter  or  guidewires
an  induce  misalignment  of  the  registration.  Furthermore,
D  fused  models  are  static  and  do  not  follow  cardiac  and
espiratory  motion.  These  limits  further  explain  why  this
echnique  is  primarily  used  for  vascular  lesions  rather  than
ntracardiac  shunts.  Finally,  a  pre-procedural  CT  scan  is
equired,  thus  increasing  ionizing  irradiation.  However,  a
T  scan  is  often  available  from  the  routine  screening  of
omplex  CHD.  Thus,  the  objective  of  3D-Roadmapping  is
o  optimize  the  use  of  CT  scans.  This  has  been  done  ini-
ially  for  diagnostic  purposes  and  can  also  be  a  helpful  tool
uring  the  interventional  procedure  to  decrease  ionizing
adiation.Aortic  (re)coarctation  stenting  is  usually  performed
nder  ﬂuoroscopy  alone  in  most  centres.  Some  groups  sug-
est  that  fusion  imaging  may  be  useful  to  facilitate  device
ositioning  with  reduced  ﬂuoroscopy  time  [9]. For  example,
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Figure 8. Aortic coarctation stenting with 3D-CT Roadmapping. Endovascular treatment of a 38-year-old woman with Roadmapping. A
and B. The aortic isthmus was much narrowed (and endovascular repair was performed using image fusion). B. First, image fusion allowed
the C-arm to be placed for the optimal view of the aortic isthmus, without X-ray exposure. Once positioned, a catheter was placed into the
supra-isthmic aorta via femoral access. C. Catheter positioning was controlled on the fused image (without injection of contrast agents).
tent 
ﬁnal 
bD. Stent positioning and angiography was performed just before s
StentTM Numed Hopkinton, NY, USA) was performed F. with a good 
Fig.  8  shows  the  case  of  a  38-year-old  woman  with  aortic
coarctation  stenting  using  Roadmapping.
Pulmonary  artery  dilation  and  stenting  remains  a  long
and  complex  procedure,  which  is  performed  under  ﬂuo-
roscopy  alone  in  most  cases,  though  Roadmapping  is  used
r
i
r
tdelivery. E. Angioplasty with implantation of a covered stent (CP
result.
y  some  operators.  Pre-acquired  3D  images  using  CT  or
otational  angiography  are  merged  with  live  ﬂuoroscopy
mages.  In  these  cases,  the  3D  images  are  segmented  and
econstructed  at  the  beginning  of  the  intervention  and  are
hen  superimposed  on  the  ﬂuoroscopy  image.  This  real-time
140  S. Hascoët  et  al.
Figure 9. Pulmonary stenosis stenting with 3D-CT Roadmapping. In case of pulmonary artery stenosis, the optimal position to correctly
expose the narrowed segment is sometimes difﬁcult to deﬁne. A. In this example of left pulmonary artery stenosis, the CT scan-derived
image fusion allowed, without any more X-ray exposure, to place the X-ray system in the optimal position to see the stenosis (white arrow),
while (B) exposing perfectly pulmonary bifurcation and lobar pulmonary artery. Angiography is performed at the beginning of the procedure
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co check the accuracy of the fused image. The rest of the proced
nspection.
ulti-modality  approach  allows  virtual  planning  of  stent  or
alve  implantation  by  3D  visualization  of  the  pulmonary
rtery  tract.  The  ﬂuoroscopy  incidence  that  is  the  best  to
uide  the  procedure  can  be  determined  using  the  fusion
mage  without  the  need  for  complementary  angiography.
tent  positioning  would  be  facilitated.  However,  it  remains
ittle  used  for  live  guidance  as  CT-derived  Roadmap  images
re  static  and  not  synchronized  to  respiratory  motion  or  posi-
ion  changes.  Figs.  7  and  9  show  examples  of  pulmonary
rtery  stenosis  stenting  and  transcatheter  pulmonary  valve
eplacement  using  Roadmapping.
RI-guided catheterization
ome  teams  have  developed  MRI-guided  catheterization,
hough  many  issues  had  to  be  overcome  [55]. First,  real-time
RI  was  developed,  combining  acquisition,  reconstruction
nd  display  with  low  latency  (<  250  ms).  In  real-time  MRI,
he  imaging  matrix,  and  thus  spatial  resolution,  is  reduced  in
ize  to  support  an  imaging  speed  of  5—10  frames  per  second.
econd,  both  haemodynamic  and  electrocardiographic  mon-
toring  equipment  had  to  be  adapted.  Third,  a  speciﬁc  MRI
atheter  without  a  heating  phenomenon  had  to  be  devel-
ped.  These  catheters  are  ‘passive’  or  ‘active’  depending
n  whether  they  are  visualized  based  on  intrinsic  material
roperties  or  based  on  signals  from  embedded  receiver  coils
nd  electronics.  However,  recent  studies  in  adults  have  sug-
ested  that  some  procedures,  such  as  MRI-guided  right  heart
atheterization,  can  be  performed  safely  and  successfully
n  approximately  the  same  amount  of  time  as  a  classical
-ray-guided  procedure  [56].  Furthermore,  following  thera-
eutic  procedures  such  as  a  percutaneous  closure  of  septal
efects  or  aortic  coarctation  stenting  in  animals  [56—58],
RI-only  guided  pulmonary  valvuloplasty  procedures  have
ecently  been  performed  [59].  These  works  begin  translation
f  cardiovascular  interventional  MRI  into  clinical  practice.
esides  the  lack  of  irradiation,  MRI  provides  superb  tissue
s
r
o
twas performed without angiography until stent delivery and ﬁnal
isualization  as  well  as  blood  ﬂow.  However,  the  logistical
omplexity,  a  reduced  temporal  and  spatial  resolution,  and
he  limited  range  of  suitable  catheters  and  devices  still  limit
ts  use.
D printing
x-vivo  modelling  and  visualization  of  intracardiac  anatomy
f  CHD  is  now  feasible  using  3D  printing  [60,61].  Printing
as  been  used  by  surgeons  to  prepare  and  check  the  fea-
ibility  of  complex  cardiac  surgeries,  such  as  double-outlet
ight  ventricle  intra-ventricular  repair  [60—62]. There  is  a
ide  spectrum  of  potential  applications  for  the  percuta-
eous  treatment  of  CHD.  For  example,  modelling  of  the  right
entricular  outﬂow  tract  could  be  used  to  check  the  feasibil-
ty  of  percutaneous  pulmonary  valve  replacement  [3,21,60].
ather  than  doing  per-procedural  ASD  balloon  sizing,  we
ould  imagine  that  the  device  could  be  selected  and  tested
ased  on  an  ex-vivo  ASD  model.  In  the  same  way,  device  type
nd  size  choice  might  be  easier  for  complex  muscular  VSD
losure.  Modelling  could  also  be  used  for  a  simulation-based
raining  programme  [63].  However,  before  3D  printing  can
e  used  in  current  practice,  many  technical  concerns  have  to
e  overcome,  with  regards  to  feasibility,  cost  and  accuracy.
onclusions
ardiac  imaging  has  greatly  contributed  to  advances  in  the
atheterization  of  CHD.  Practices  vary  widely  by  operator
nd  centre.  Fluoroscopy  remains  the  cornerstone  technique
nd  continuous  efforts  are  undertaken  to  decrease  the  asso-
iated  irradiation.  2D  and  3D  echocardiography  have  become
omplementary  useful  tools,  particularly  during  intracardiac
hunt  closure.  Fusion  imaging,  between  CT  or  echocardiog-
aphy  and  ﬂuoroscopy,  further  extends  the  armamentarium
f  cardiac  imaging  modalities  in  the  catheterization  labora-
ory  and  its  effect  is  under  investigation.
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